Scholars Central

Conference abstractPublished 2 Nov 2015

Isoindolines as potential modulators of human histone deacetylase: New discovery

Authors: José Bribiesca Carlos, Erik Andrade Jorge, José Guadalupe Trujillo Ferrara, Ernesto Daniel Guevara Avendaño, Luis Daniel Manzano Ruiz

Instituto PolitÃ?©cnico Nacional, MÃ?©xico

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer is a disease that is taking great importance in societies worldwide, so that has been earmarked much of the worldâÂ?Â?s resources in finding an effective treatment. Currently, it is intended that new anticancer drugs to be more selective and do not generate side effects. This has been possible with new technologies that allow us to develop drugs with high selectivity to act at a specific level by inhibiting important processes in the cancer cells. The aim of this work was to develop a series of isoindolines as inhibitors of HDAC (Histone Deacetylase), a key enzyme in the transcription of genetic information; the purpose of these ligands is inhibition of histone deacetylase leading to a hyper-acetylation state to allow transcription of anti-oncogenes like NFÃ?ºB, p53, Ku70, tubulin, among others. The results demonstrate that our compound decreases cell viability at the concentration of 1x10-3 M at 24 and 48 hours, the results were obtained by two methods: through spectroscopy at 540 nm and cell counting performed by a cell counter. The compound decreased the cell viability 50% at 24 hours and 20% at 48 h (p<0.05). In spite of these excellent results we found a second effect that is related with cell proliferation at concentrations lower than 1x10-7 M, setting a new question on the table: what is the mechanism of this biphasic effect? Therefore, it is necessary research in different cell lines to test their proliferative effect and its possible applications.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “José Bribiesca Carlos”
  • BylineArticles whose byline prints “Erik Andrade Jorge”
  • BylineArticles whose byline prints “José Guadalupe Trujillo Ferrara”
  • BylineArticles whose byline prints “Ernesto Daniel Guevara Avendaño”
  • BylineArticles whose byline prints “Luis Daniel Manzano Ruiz”